AAAAAA
Results:
1-14
|
Results: 14
Authors:
Spencer, T
Biederman, J
Heiligenstein, J
Wilens, T
Faries, D
Prince, J
Faraone, SV
Rea, J
Witcher, J
Zervas, S
Citation: T. Spencer et al., An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder, J CH AD PSY, 11(3), 2001, pp. 251-265
Authors:
Wolraich, ML
Greenhill, LL
Pelham, W
Swanson, J
Wilens, T
Palumbo, D
Atkins, M
McBurnett, K
Bukstein, O
August, G
Citation: Ml. Wolraich et al., Randomized, controlled trial of OROS methylphenidate once a day in children with attention-deficit/hyperactivity disorder, PEDIATRICS, 108(4), 2001, pp. 883-892
Authors:
Faraone, SV
Biederman, J
Mick, E
Doyle, AE
Wilens, T
Spencer, T
Frazier, E
Mullen, K
Citation: Sv. Faraone et al., A family study of psychiatric comorbidity in girls and boys with attention-deficit/hyperactivity disorder, BIOL PSYCHI, 50(8), 2001, pp. 586-592
Authors:
Spencer, T
Biederman, J
Wilens, T
Faraone, S
Prince, J
Gerard, K
Doyle, R
Parekh, A
Kagan, J
Bearman, SK
Citation: T. Spencer et al., Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder, ARCH G PSYC, 58(8), 2001, pp. 775-782
Authors:
Spencer, TJ
Biederman, J
Faraone, S
Mick, E
Coffey, B
Geller, D
Kagan, J
Bearman, SK
Wilens, T
Citation: Tj. Spencer et al., Impact of tic disorders on ADHD outcome across the life cycle: Findings from a large group of adults with and without ADHD, AM J PSYCHI, 158(4), 2001, pp. 611-617
Authors:
Spencer, T
Biederman, J
Wilens, T
Citation: T. Spencer et al., Pharmacotherapy of attention deficit hyperactivity disorder, CH ADOLESC, 9(1), 2000, pp. 77
Authors:
Spencer, T
Biederman, J
Wozniak, J
Wilens, T
Citation: T. Spencer et al., Attention deficit hyperactivity disorder and affective disorders in childhood: continuum, comorbidity or confusion, CUR OPIN P, 13(1), 2000, pp. 73-79
Authors:
Asherson, P
Barkley, R
Barr, C
Berg, K
Biederman, J
Castellanos, X
Comings, D
Curran, S
Doyle, A
Ebstein, R
Eisenberg, J
Ergelen, E
Faraone, S
Freund, L
Geller, D
Gill, M
Holmes, J
Hudziak, J
Kennedy, J
Kent, L
Manor, I
Mick, E
Mitchell, H
Navia, B
Pato, C
Pato, M
Price, T
Sargeant, J
Simonoff, E
Smalley, S
Spencer, T
Swanson, J
Waldman, I
Wilens, T
Yazgan, Y
Citation: P. Asherson et al., Collaborative possibilities for molecular genetic studies of attention deficit hyperactivity disorder: Report from an international conference, AM J MED G, 96(3), 2000, pp. 251-257
Authors:
Faraone, SV
Biederman, J
Spencer, T
Wilens, T
Seidman, LJ
Mick, E
Doyle, AE
Citation: Sv. Faraone et al., Attention-deficit/hyperactivity disorder in adults: An overview, BIOL PSYCHI, 48(1), 2000, pp. 9-20
Authors:
Faraone, SV
Biederman, J
Mick, E
Williamson, S
Wilens, T
Spencer, T
Weber, W
Jetton, J
Kraus, I
Pert, J
Zallen, B
Citation: Sv. Faraone et al., Family study of girls with attention deficit hyperactivity disorder, AM J PSYCHI, 157(7), 2000, pp. 1077-1083
Authors:
Cohen, LG
Prince, J
Biederman, J
Wilens, T
Faraone, SV
Whitt, S
Mick, E
Spencer, T
Meyer, MC
Polisner, D
Flood, JG
Citation: Lg. Cohen et al., Absence of effect of stimulants on the pharmacokinetics of desipramine in children, PHARMACOTHE, 19(6), 1999, pp. 746-752
Authors:
Biederman, J
Wilens, T
Mick, E
Spencer, T
Faraone, SV
Citation: J. Biederman et al., Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder, PEDIATRICS, 104(2), 1999, pp. E201-E205
Authors:
Spencer, T
Biederman, J
Wilens, T
Citation: T. Spencer et al., Attention-deficit/hyperactivity disorder and comorbidity, PED CLIN NA, 46(5), 1999, pp. 915
Authors:
Spencer, T
Biederman, J
Coffey, B
Geller, D
Wilens, T
Faraone, S
Citation: T. Spencer et al., The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder, ARCH G PSYC, 56(9), 1999, pp. 842-847
Risultati:
1-14
|